ClinicalTrials.govpublic full text
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
clinical stage i gastroesophageal junction adenocarcinoma ajcc v8, clinical stage ii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iia gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iib gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 356488
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.